Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Liver Cancer
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Journal:
Journal for immunotherapy of cancer
Published —
March 20, 2021
Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial.
Condition:
Hepatocellular Carcinoma with Child-Pugh B Cirrhosis
Journal:
The British journal of surgery
Treatment Used:
Laparoscopic and Open Liver Resection for Hepatocellular Carcinoma
Number of Patients:
382
Published —
March 12, 2021
The study compared the outcomes between Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis.
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Sorafenib and Lenvatinib
Number of Patients:
0
Published —
March 11, 2021
This article discusses the use of lenvatinib and sorafenib in the first-line management of patients with hepatocellular carcinoma (liver cancer; HCC).
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Immunotherapy
Number of Patients:
0
Published —
March 11, 2021
This article discusses the role of immunotherapy in the treatment of patients with hepatocellular carcinoma (liver cancer; HCC).
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Second-Line Systemic Treatment
Number of Patients:
0
Published —
March 11, 2021
This article discusses the second-line systemic treatment for patients with hepatocellular carcinoma (liver cancer; HCC).
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Second-Line Therapy
Number of Patients:
1280
Published —
March 11, 2021
This review of the literature compared the benefits and toxicities between sorafenib and second-line therapy in patients with advanced hepatocellular carcinoma (liver cancer; HCC).
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Locoregional Therapies
Number of Patients:
0
Published —
March 11, 2021
This article discusses current locoregional therapies (LRTs) in the treatment of patients with hepatocellular carcinoma (liver cancer; HCC).
Condition:
Peribiliary Hepatocellular Carcinoma
Journal:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Treatment Used:
Microwave Ablation
Number of Patients:
236
Published —
March 08, 2021
The study researched the use of microwave ablation for patients with peribiliary hepatocellular carcinoma.
Condition:
Cirrhotic Patients with Early Hepatocellular Carcinoma (HCC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Percutaneous Microwave (MWA) vs. Radiofrequency Ablation (RFA)
Number of Patients:
251
Published —
March 06, 2021
This study compared the effectiveness of percutaneous microwave ablation (MWA) versus radiofrequency ablation (RFA) in patients with very early or early hepatocellular carcinoma (liver cancer; HCC).
Condition:
Hepatocellular Carcinoma
Journal:
PloS one
Treatment Used:
Yttrium-90 Transarterial Radioembolization
Number of Patients:
1439
Published —
March 04, 2021
In this study, researchers evaluated the outcomes of using yttrium-90 transarterial radioembolization for the treatment of non-surgical hepatocellular carcinoma.
Condition:
Chronic Hepatitis C
Journal:
Medicina (Kaunas, Lithuania)
Treatment Used:
Direct-Acting Antiviral Drugs
Number of Patients:
0
Published —
March 03, 2021
This study evaluated changes in liver fibrosis and the risk of developing hepatocellular carcinoma after direct-acting antiviral drug therapy in patients with chronic hepatitis C virus infection.
Condition:
Patients with Cancer Undergoing Surgery
Journal:
Integrative cancer therapies
Treatment Used:
Supplemental Branched-Chain Amino Acids
Number of Patients:
0
Published —
March 02, 2021
This review of the literature evaluated the safety and effectiveness of branched-chain amino acids (BCAAs) in the treatment of patients with cancer undergoing surgery.
Showing 1-12 of 1258
Next